| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.28 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |